(19)
(11) EP 1 137 386 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.10.2006 Bulletin 2006/40

(45) Mention of the grant of the patent:
03.05.2006 Bulletin 2006/18

(21) Application number: 99940451.0

(22) Date of filing: 23.06.1999
(51) International Patent Classification (IPC): 
A61K 6/00(2006.01)
(86) International application number:
PCT/IN1999/000026
(87) International publication number:
WO 2001/000138 (04.01.2001 Gazette 2001/01)

(54)

USE OF TRICLOSAN AS AN ANTIMALARIAL AGENT

VERWENDUNG VON TRICLOSAN ALS ANTIMALARIAMITTEL

UTILISATION DU TRICLOSAN COMME AGENT ANTI-MALARIA

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(43) Date of publication of application:
04.10.2001 Bulletin 2001/40

(73) Proprietors:
  • Jawaharlal Nehru Centre For Advanced Scientific Research
    Jakkur, Bangalore 560 064 (IN)
  • Surolia, Namita
    Bangalore 560 012 (IN)

(72) Inventors:
  • SUROLIA, Namita Indian Institute of Science
    Bangalore 560 012 (IN)
  • SUROLIA, Avadhesha Indian Institute of Science
    Bangalore 560 012 (IN)

(74) Representative: McNab, Donald C. et al
Novagraaf Patents Limited The Crescent 54 Blossom Street
York YO24 1AP
York YO24 1AP (GB)


(56) References cited: : 
EP-A1- 0 474 597
   
  • DATABASE MEDLINE [Online] HEATH ET AL.: 'Mechanism of triclosan inhibition of bacterial fatty acid synthesis', XP002907177 Database accession no. 10196195 & J. BIOL. CHEM. vol. 274, no. 16, April 1999, pages 11110 - 11114
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).